This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Steven Kovats: Innovator in Cancer Treatment
Introduction
Steven Kovats is a prominent inventor based in Wilmington, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of combination therapies. With a total of 2 patents, Kovats is recognized for his work in advancing medical science.
Latest Patents
Kovats' latest patents focus on combination therapies that utilize a CDK4/6 inhibitor and a PI3K inhibitor for the treatment of cancer. These patents include:
1. Combination therapy comprising a CDK4/6 inhibitor and a PI3K inhibitor for use in the treatment of cancer.
2. A combination of a CDK4/6 inhibitor and a PI3K inhibitor for the treatment of cancer.
Career Highlights
Steven Kovats is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in oncology.
Collaborations
Kovats has worked alongside talented colleagues such as Sunkyu Kim and Shivang Doshi. Their collaborative efforts have further enhanced the development of innovative cancer therapies.
Conclusion
Steven Kovats is a dedicated inventor whose work in combination therapies is paving the way for new cancer treatments. His contributions to the field are invaluable and continue to inspire advancements in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile